Connect your AI

Douglas Elliman DOUG Debt Securities, Current

Debt Securities, Current at other companies

Mineralys Therapeutics, Inc.MLYS

$533.28M+200%

Aurinia PharmaceuticalsAUPH

$337.78M+37.0%

XencorXNCR

$370.21M-2.8%

BlockXYZ

$462.61M+30.4%

NikeNKE

$1.4B-22.0%

3MMMM

$420M-39.8%

Other financials

Income statement

Revenue$214.3M-15.4%

Operating income-$17.5M-227%

Net income-$16.3M-172%

EPS (diluted)-$0.19-171%

Balance sheet

Cash & equivalents$103.0M-29.2%

Total debt$101.8M-32.8%

Total equity$168.1M+6.2%

Total assets$435.2M-11.9%

Cash flow

Operating cash flow-$19.3M-244%

CapEx$259.0K-75.0%

Free cash flow-$19.6M-195%

Valuation

Market cap$160.9M-25.1%

Enterprise value$159.72M-26.4%

P/E32.7×—

P/S0.2×0.0×

Profitability

Operating margin3.4%+2.3pp

Net margin0.5%+0.3pp

FCF margin7.4%—

Returns & leverage

Return on equity3%+1.6pp

Debt / equity0.6×-0.4×

Current ratio1.5×-0.5×

Where this comes from

Reported directly by Douglas Elliman in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesCurrent.

The official record: Douglas Elliman’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Douglas Elliman's debt securities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Douglas Elliman's debt securities, current?: Douglas Elliman (DOUG) reported debt securities, current of $1.23M in Q1 2026.